Pfizer's latest COVID booster targets Omicron JN.1. Learn who should get it and why it’s essential for protection.

For young, healthy people who may be wondering, “do I need a COVID booster at all?”, having one annually is sensible.

Endocrinologist Olga Duchon, MD, was fatally shot over the weekend in suburban Chicago less than 2 hours after giving a talk ...

Australia's Therapeutic Goods Administration has approved a new COVID booster by Pfizer targeting the JN.1 sub-variant of Omicron. Despite evolving variants, boosters remain crucial, especially for ...

Ongoing studies shows why covid 19 protection wanes over time. Know the factors behind waning immunity, why booster doses are ...

The absolute number of COVID-19 deaths was three times higher than those from flu, but the case-fatality ratio was comparable ...

Pfizer and partner BioNTech have started their clinical trial of a new version of their COVID-19 vaccine that has been specifically designed to protect against the Omicron variant. The trial in ...

UK researchers have analysed the likely impact that a Covid booster shot will have on Omicron and say it could provide around ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved an adapted version of the Nuvaxovid COVID-19 vaccine that targets the ...

Lassa fever, which was first isolated at Yale, is a rare virus that is mostly transmitted in West Africa. Those infected with ...

The study was based on outcomes seen among essential workers with COVID-19 infection from June 2021 to September 2022.

There was also a 65% relative reduction in COVID-related medical visits (95% CI 24.4-83.8) with nirmatrelvir-ritonavir versus ...